Maria C. Carrillo

Maria C. Carrillo

Auto-generated profile, based on publicly available information

Maria C. Carrillo

Alzheimer's Association, Chicago, IL; and

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
HSHeather M. Snyder
Heather M. Snyder
MCMaria C. Carrillo
Maria C. Carrillo
FGFrancine Grodstein
Francine Grodstein
KHKim Henriksen
Kim Henriksen
AJAndreas Jeromin
Andreas Jeromin
HFHoward M. Fillit
Howard M. Fillit

21 September 2021 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
EMEric McDade
Eric McDade
IVIryna Voytyuk
Iryna Voytyuk
PAPaul Aisen
Paul Aisen
RBRandall J. Bateman
Randall J. Bateman
MCMaria C. Carrillo
Maria C. Carrillo
SLStefan F. Lichtenthaler
Stefan F. Lichtenthaler

15 March 2017 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
JKJason Karlawish
Jason Karlawish
CJClifford R. Jack
Clifford R. Jack
WRWalter A. Rocca
Walter A. Rocca
HSHeather M. Snyder
Heather M. Snyder
MCMaria C. Carrillo
Maria C. Carrillo

1 November 2014 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PSPeter J. Snyder
Peter J. Snyder
KKKristin Kahle‐Wrobleski
Kristin Kahle‐Wrobleski
SBStephen Brannan
Stephen Brannan
DMDavid S. Miller
David S. Miller
RSRachel J. Schindler
Rachel J. Schindler
MCMaria C. Carrillo
Maria C. Carrillo

1 October 2014 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AWAlzheimer's Association National Plan Milestone Workgroup
Alzheimer's Association National Plan Milestone Workgroup
KFKeith N. Fargo
Keith N. Fargo
PAPaul Aisen
Paul Aisen
MAMarilyn Albert
Marilyn Albert
RARhoda Au
Rhoda Au
MCMaria C. Carrillo
Maria C. Carrillo
With increasing numbers of people with Alzheimer's and other dementias across the globe, many countries have developed national plans to deal with the resulting challenges. In the United States, the National Alzheimer's Project Act, signed into law in 2011, required the creation of such a plan with annual updates thereafter. Pursuant to this, the US Department of Health and Human Services (HHS) released the National Plan to Address Alzheimer's Disease in 2012, including an ambitious research goal of preventing and effectively treating Alzheimer's disease by 2025. To guide investments, activities, and the measurement of progress toward achieving this 2025 goal, in its first annual plan update (2013) HHS also incorporated into the plan a set of short, medium and long‐term milestones. HHS further committed to updating these milestones on an ongoing basis to account for progress and setbacks, and emerging opportunities and obstacles. To assist HHS as it updates these milestones, the Alzheimer's Association convened a National Plan Milestone Workgroup consisting of scientific experts representing all areas of Alzheimer's and dementia research. The workgroup evaluated each milestone and made recommendations to ensure that they collectively constitute an adequate work plan for reaching the goal of preventing and effectively treating Alzheimer's by 2025. This report presents these Workgroup recommendations.

1 June 2014 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LSLeslie Sibener
Leslie Sibener
IZIbrahim Zaganjor
Ibrahim Zaganjor
HSHeather M. Snyder
Heather M. Snyder
LBLisa J. Bain
Lisa J. Bain
RERobert Egge
Robert Egge
MCMaria C. Carrillo
Maria C. Carrillo
By 2050, more than 13 million Americans of all ages are estimated to be living with Alzheimer's disease (AD), and the aggregate costs of care will swell to approximately $1.2 trillion. The rapidly climbing number of those affected with AD includes a growing population of aging military veterans affected who may have an added risk for the disease as a consequence of traumatic brain injury, posttraumatic stress disorder, and/or service‐related injuries. The increasing number of individuals, the long duration of disability, and the rising cost of care for AD and other dementia to our society are important public health challenges facing many older adults. These challenges are further compounded by a burgeoning military veteran population that is much younger, with an increased risk of AD and other dementia, and who may experience decades‐long periods of disability and care. This outlook underscores the critical need for investments in research at the federal and international levels to accelerate the pace of progress in developing breakthrough discoveries that will change the trajectory of AD and related dementia.